Lumida
/IPSC
⌘K
Century Therapeutics Inc

Century Therapeutics Inc

IPSC
$1.94USD+0.00%+0.00 today

MARKET CAP

351.3M

P/E (TTM)

FWD P/E

DAY RANGE

$2 – $2

52W RANGE

$0
$3
STATEMENT·Income statement
USD · GAAP
METRICFY 2022FY 2023FY 2024FY 2025TREND
Sales, Adj.$5.2M$2.2M$6.6M$109.2M
YoY %-57.0%+194.8%+1556.8%
P / Sales55.2x96.6x12.1x0.8x
EV / Sales74.4x154.1x32.3x0.8x
Gross Profit, Adj.$5.2M$2.2M$6.6M$109.2M
YoY %-57.0%+194.8%+1556.8%
Margin %100.0%100.0%100.0%100.0%
EV / Gross Profit74.4x154.1x32.3x0.8x
EBITDA, Adj.$-125.4M$-117.1M$-120.5M$2.6M
YoY %-37.6%+6.6%-2.9%+102.2%
Margin %-2411.8%-5241.0%-1828.9%2.4%
EV / EBITDA-3.1x-2.9x-1.8x34.3x
EBIT$-133.8M$-146.5M$-138.1M$-17.3M
YoY %-41.0%-9.5%+5.7%+87.5%
Margin %-2574.2%-6556.9%-2096.5%-15.8%
EV / EBIT-2.9x-2.4x-1.5x-5.2x
Net Income$-130.9M$-136.7M$-126.6M$-9.6M
YoY %-36.6%-4.4%+7.4%+92.4%
Net Margin-2518.4%-6115.1%-1920.9%-8.8%
EPS (GAAP)-$2.27-$2.30-$1.61-$0.14
YoY %+23.3%-1.3%+30.0%+91.3%